Louis Groignet, David Dellemme, Quentin Duez, Afaf Fizazi, Jean-Marie Colet, Patrick Brocorens, Mathieu Surin, Pascal Gerbaux and Julien De Winter*,
{"title":"翻译后琥珀化对小泛素样修饰剂1结构的影响:气相和溶液研究的双重方法","authors":"Louis Groignet, David Dellemme, Quentin Duez, Afaf Fizazi, Jean-Marie Colet, Patrick Brocorens, Mathieu Surin, Pascal Gerbaux and Julien De Winter*, ","doi":"10.1021/acsptsci.5c00259","DOIUrl":null,"url":null,"abstract":"<p >SUMO1 (small ubiquitin-like modifier 1) is a key protein involved in the post-translational modification of a wide range of substrate proteins. SUMOylation plays a pivotal role in regulating various cellular processes such as protein localization, functional modulation, and complex formation. Notably, SUMO1 contains a cysteine residue in its sequence, making it susceptible to succination, i.e., a Michael addition of cysteine onto fumarate, forming a succinated cysteine. This could occur under conditions of elevated intracellular fumarate concentration, a hallmark of metabolic dysregulation. To investigate this hypothesis, we employ a multidisciplinary approach integrating advanced analytical techniques such as mass spectrometry (including liquid chromatography, ion mobility spectrometry, and hydrogen–deuterium exchange experiments), circular dichroism spectroscopy, and molecular dynamics simulations. We demonstrate that SUMO1 undergoes succination <i>in vitro</i>, leading to important conformational changes. These findings provide insights into the susceptibility of SUMO1 to metabolic alterations.</p>","PeriodicalId":36426,"journal":{"name":"ACS Pharmacology and Translational Science","volume":"8 8","pages":"2683–2693"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of Post-Translational Succination on Small Ubiquitin-Like Modifier 1 Structure: A Dual Approach Combining Gas Phase and Solution Studies\",\"authors\":\"Louis Groignet, David Dellemme, Quentin Duez, Afaf Fizazi, Jean-Marie Colet, Patrick Brocorens, Mathieu Surin, Pascal Gerbaux and Julien De Winter*, \",\"doi\":\"10.1021/acsptsci.5c00259\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >SUMO1 (small ubiquitin-like modifier 1) is a key protein involved in the post-translational modification of a wide range of substrate proteins. SUMOylation plays a pivotal role in regulating various cellular processes such as protein localization, functional modulation, and complex formation. Notably, SUMO1 contains a cysteine residue in its sequence, making it susceptible to succination, i.e., a Michael addition of cysteine onto fumarate, forming a succinated cysteine. This could occur under conditions of elevated intracellular fumarate concentration, a hallmark of metabolic dysregulation. To investigate this hypothesis, we employ a multidisciplinary approach integrating advanced analytical techniques such as mass spectrometry (including liquid chromatography, ion mobility spectrometry, and hydrogen–deuterium exchange experiments), circular dichroism spectroscopy, and molecular dynamics simulations. We demonstrate that SUMO1 undergoes succination <i>in vitro</i>, leading to important conformational changes. These findings provide insights into the susceptibility of SUMO1 to metabolic alterations.</p>\",\"PeriodicalId\":36426,\"journal\":{\"name\":\"ACS Pharmacology and Translational Science\",\"volume\":\"8 8\",\"pages\":\"2683–2693\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-07-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Pharmacology and Translational Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsptsci.5c00259\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Pharmacology and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsptsci.5c00259","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Impact of Post-Translational Succination on Small Ubiquitin-Like Modifier 1 Structure: A Dual Approach Combining Gas Phase and Solution Studies
SUMO1 (small ubiquitin-like modifier 1) is a key protein involved in the post-translational modification of a wide range of substrate proteins. SUMOylation plays a pivotal role in regulating various cellular processes such as protein localization, functional modulation, and complex formation. Notably, SUMO1 contains a cysteine residue in its sequence, making it susceptible to succination, i.e., a Michael addition of cysteine onto fumarate, forming a succinated cysteine. This could occur under conditions of elevated intracellular fumarate concentration, a hallmark of metabolic dysregulation. To investigate this hypothesis, we employ a multidisciplinary approach integrating advanced analytical techniques such as mass spectrometry (including liquid chromatography, ion mobility spectrometry, and hydrogen–deuterium exchange experiments), circular dichroism spectroscopy, and molecular dynamics simulations. We demonstrate that SUMO1 undergoes succination in vitro, leading to important conformational changes. These findings provide insights into the susceptibility of SUMO1 to metabolic alterations.
期刊介绍:
ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered.
ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition.
Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.